Study of OTSA101 in patients with Synovial Sarcomas

Trial Profile

Study of OTSA101 in patients with Synovial Sarcomas

Planning
Phase of Trial: Phase I

Latest Information Update: 28 Mar 2016

At a glance

  • Drugs OTSA 101-Y 90 (Primary)
  • Indications Synovial sarcoma
  • Focus Adverse reactions
  • Sponsors OncoTherapy Science
  • Most Recent Events

    • 28 Mar 2016 New trial record
    • 23 Mar 2016 According to OncoTherapy media release, company is planning to initiate this trial for the new drug application in Japan, USA and EU.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top